- Astaxanthin is a red carotenoid antioxidant from the microalga Haematococcus pluvialis.
- It is studied as far stronger than vitamins C and E, protecting cell membranes from both the water and fat sides.
- Studied benefits span anti-ageing, skin, muscle, cardiovascular, eyes and immune support.
- Natural-source astaxanthin is studied as superior to synthetic; it pairs with mushroom polysaccharides in immune-support formulas.
What is astaxanthin?
Astaxanthin is a red-coloured carotenoid extracted from the microalga Haematococcus pluvialis. This alga usually grows where sunlight is especially intense, and astaxanthin protects its cells from the harmful oxidative compounds caused by the sun's UV rays — without it, intense sunlight would simply destroy the algae's cellular DNA. Natural astaxanthin has a unique molecular structure, and it is precisely this structure that makes it studied as hundreds of times stronger than many other known antioxidants. For protecting cell membranes, astaxanthin is studied as more than 65 times stronger than vitamin C and 50 times stronger than vitamin E; for scavenging free radicals, it is studied as far stronger than vitamin C. Unlike many antioxidants, its structure lets it protect the cell membrane from both sides — the water side and the fat side.
The benefits of astaxanthin
Anti-ageing: studies suggest astaxanthin protects mitochondria far more effectively than vitamin E, and reduces free-radical DNA damage. Skin: natural astaxanthin is studied for optimising skin health — reducing inflammation across skin layers, reducing wrinkle size, improving microtexture and elasticity. Muscle: studied for supporting muscle function and endurance, reducing lactic-acid build-up and fatigue, and improving blood flow. Cardiovascular: studied for reducing oxidative stress and inflammation, improving the lipid profile and capillary circulation. Eyes: studied for reducing eye fatigue and irritation and supporting visual quality. Immune system: studied for both balancing and strengthening immunity — a faster immune response, enhanced antibody production, and protection of immune cells from oxidative damage.
Astaxanthin, immunity and oncology support
Because astaxanthin is studied for protecting immune cells from oxidative damage and for supporting a balanced immune response, it is one of the components combined in concentrated immune-support formulas during oncological disease. Its role there is as an antioxidant partner to the mushroom polysaccharides — protecting the very immune cells (such as NK cells) that the polysaccharides are studied for activating.
What to know before buying
Source matters: natural astaxanthin from Haematococcus pluvialis is studied as superior to synthetic astaxanthin (often derived from petrochemicals), which has a different molecular configuration. Look for natural-source, standardised products. As a fat-soluble compound, astaxanthin is best absorbed with a meal containing fat. In a formula, its value is as a concentrated, standardised antioxidant working alongside other actives, not as a cheap filler.
Lentinan AXT by Zenius Labs™ combines Lentinus edodes and Coriolus versicolor mushroom polysaccharides with astaxanthin - the carotenoid in this article acts as the antioxidant partner protecting the immune cells the polysaccharides are studied for activating.
Lentinan AXT by Zenius Labs™ →Astaxanthin is a red carotenoid antioxidant extracted from the microalga Haematococcus pluvialis, which produces it to protect its own cells from intense UV damage. Its unique structure is studied as making it hundreds of times stronger than many other antioxidants.
For protecting cell membranes it is studied as more than 65 times stronger than vitamin C and 50 times stronger than vitamin E, and it uniquely protects the membrane from both the water and fat sides.
It is studied for anti-ageing (mitochondrial and DNA protection), skin health, muscle endurance and recovery, cardiovascular support (lipid profile, circulation), eye fatigue, and immune support (faster response, antibody production, protecting immune cells).
Natural astaxanthin from Haematococcus pluvialis is studied as superior to synthetic (often petrochemical-derived) astaxanthin, which has a different molecular configuration. As a fat-soluble compound, it is best absorbed with a meal containing fat.
- Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis. PubMed
- Astaxanthin improved acute and chronic digital eye strain in children: A randomized double-blind placebo-controlled trial. PubMed
- Astaxanthin Protects Dendritic Cells from Lipopolysaccharide-Induced Immune Dysfunction. PubMed
- Astaxanthin and β-carotene in Helicobacter pylori-induced Gastric Inflammation. PubMed
- Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease. PubMed
- Astaxanthin protects oxidative stress mediated DNA damage and enhances longevity. PubMed
- Astaxanthin as a neuroprotective modulator of synaptic plasticity, learning, and memory. PubMed
- Wang Y et al. Systematic review and meta-analysis on the efficacy and safety of Injectable Lentinan combined with chemotherapy in the treatment of gastric cancer. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. PubMed
- Oba K et al. Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer research. 2009. PubMed
- Wang Y et al. Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis. Medicine. 2024. PubMed
- Zhang M et al. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China. Progress in molecular biology and translational science. 2019. PubMed
- Yin X et al. A meta-analysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer. Indian journal of cancer. 2015. PubMed
- Baral B Holistic Evaluation of Shiitake mushrooms (Lentinula edodes): Unraveling Its Medicinal and Therapeutic Potentials. Chemistry & biodiversity. 2025. PubMed
- Ooi SL et al. Modified Rice Bran Arabinoxylan by Lentinus edodes Mycelial Enzyme as an Immunoceutical for Health and Aging-A Comprehensive Literature Review. Molecules (Basel, Switzerland). 2023. PubMed
- Choi JY et al. Dietary supplementation with rice bran fermented with Lentinus edodes increases interferon-γ activity without causing adverse effects: a randomized, double-blind, placebo-controlled, parallel-group study. Nutrition journal. 2014. PubMed
- Gaullier JM et al. Supplementation with a soluble β-glucan exported from Shiitake medicinal mushroom, Lentinus edodes (Berk.) singer mycelium: a crossover, placebo-controlled study in healthy elderly. International journal of medicinal mushrooms. 2011. PubMed
- Lu H et al. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011. PubMed
- Ooshiro M et al. [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK]. Gan to kagaku ryoho. Cancer & chemotherapy. 2009. PubMed
- Tanaka H et al. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer. Anticancer research. 2012. PubMed
- Maehara Y et al. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer. Cancer chemotherapy and pharmacology. 1993. PubMed
- Ito G et al. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Experimental and therapeutic medicine. 2012. PubMed
- Standish LJ et al. Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society for Integrative Oncology. 2008. PubMed
- Eliza WL et al. Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent patents on inflammation & allergy drug discovery. 2012. PubMed
- He Z et al. Polysaccharide-Peptide from Trametes versicolor: The Potential Medicine for Colorectal Cancer Treatment. Biomedicines. 2022. PubMed
- Chang Y et al. Preclinical and clinical studies of Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Discovery medicine. 2017. PubMed
- Ziaja-Sołtys M et al. Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review. Current issues in molecular biology. 2025. PubMed
- Park JS et al. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutrition & metabolism. 2010. PubMed
- Cheng J et al. The Promising Effects of Astaxanthin on Lung Diseases. Advances in nutrition (Bethesda, Md.). 2021. PubMed
- Lee J et al. Anti-Oxidant and Anti-Inflammatory Effects of Astaxanthin on Gastrointestinal Diseases. International journal of molecular sciences. 2022. PubMed
- Wang T et al. Astaxanthin protected against the adverse effects induced by diesel exhaust particulate matter via improving membrane stability and anti-oxidative property. Journal of hazardous materials. 2023. PubMed
- He J et al. Astaxanthin Alleviates Oxidative Stress in Mouse Preantral Follicles and Enhances Follicular Development Through the AMPK Signaling Pathway. International journal of molecular sciences. 2025. PubMed
- Akramiene D et al. Effects of beta-glucans on the immune system. Medicina (Kaunas, Lithuania). 2007. PubMed
- Ross GD et al. Therapeutic intervention with complement and beta-glucan in cancer. Immunopharmacology. 1999. PubMed
- Li B et al. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. Journal of immunology (Baltimore, Md. : 1950). 2006. PubMed
- Liu J et al. Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Experimental and molecular pathology. 2009. PubMed
- Xia Y et al. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. Journal of immunology (Baltimore, Md. : 1950). 1999. PubMed
- Fang J et al. Structure of a β-glucan from Grifola frondosa and its antitumor effect by activating Dectin-1/Syk/NF-κB signaling. Glycoconjugate journal. 2012. PubMed
- Zhang M et al. β-Glucan from Saccharomyces cerevisiae induces SBD-1 production in ovine ruminal epithelial cells via the Dectin-1-Syk-NF-κB signaling pathway. Cellular signalling. 2019. PubMed
- Gringhuis SI et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nature immunology. 2009. PubMed
- Jia XM et al. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. The Journal of experimental medicine. 2014. PubMed
- Bode K et al. Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2. Cell reports. 2019. PubMed
- Zou X et al. Radioprotective effect of edible and medicinal mushrooms against ionizing radiation: Components, potential mechanisms, and applications. Food research international (Ottawa, Ont.). 2025. PubMed
- Dan A et al. Therapeutic Effects of Medicinal Mushrooms on Gastric, Breast, and Colorectal Cancer: A Scoping Review. Cureus. 2023. PubMed
- Abidin MHZ et al. Antiatherogenic Potential of Extracts from the Gray Oyster Medicinal Mushroom, Pleurotus pulmonarius (Agaricomycetes), In Vitro. International journal of medicinal mushrooms. 2018. PubMed
- Zhang X et al. Edible mushroom polysaccharides: Structural characteristics, chemical modification strategies, and structure-activity relationship: A review. International journal of biological macromolecules. 2025. PubMed
- Narayanan S et al. Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies. Current oncology reports. 2023. PubMed
- Wang H et al. Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta-analysis. Cancer medicine. 2017. PubMed
- Oba K et al. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer immunology, immunotherapy : CII. 2007. PubMed
- Cheng SC et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science (New York, N.Y.). 2014. PubMed
- Kidd P Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Alternative medicine review : a journal of clinical therapeutic. 2011. PubMed